Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Arnold J. Weil"'
Autor:
Arnold J. Weil, Elizabeth T. Masters, Alexandra I. Barsdorf, Almasa Bass, Glenn Pixton, Jacquelyn G. Wilson, Gernot Wolfram
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-7 (2017)
Abstract Background The efficacy of ALO-02, an abuse-deterrent formulation containing extended-release oxycodone and sequestered naltrexone, in the treatment of chronic low back pain (CLBP) was studied in a 12-week randomized controlled trial. Primar
Externí odkaz:
https://doaj.org/article/918dccc8e1d545fa9ea04368d35bc05b
Publikováno v:
Journal of Opioid Management. 5:39-45
Although most extended-release morphine formulations are indicated for use once-daily (q24h) or twicedaily (q12h), KADIAN® (morphine sulfate extendedrelease) capsules, which contain polymer-coated, extended-release morphine sulfate pellets, are indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993f52d422616368dc22f13defcf125a
https://doi.org/10.5055/jom.2009.0005
https://doi.org/10.5055/jom.2009.0005
Autor:
Gernot Wolfram, Almasa Bass, Glenn C. Pixton, Jacquelyn G Wilson, Arnold J. Weil, Alexandra I. Barsdorf, Elizabeth T. Masters
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-7 (2017)
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-7 (2017)
Background The efficacy of ALO-02, an abuse-deterrent formulation containing extended-release oxycodone and sequestered naltrexone, in the treatment of chronic low back pain (CLBP) was studied in a 12-week randomized controlled trial. Primary efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ebdb7cc29acde19dc4410bef208d5e
https://doi.org/10.1186/s12955-017-0749-y
https://doi.org/10.1186/s12955-017-0749-y
Diagnosis and Treatment of Low-Back Pain Because of Paraspinous Muscle Spasm: A Physician Roundtable
Publikováno v:
Pain Medicine. 12:S119-S127
Background. Despite the availability of evidence-based guidelines to diagnose and treat acute low-back pain, practical application is nonuniform and physician uncertainty regarding best practices is widespread. Objective. The objective of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91355ea2abbd93897c004ebdacb68015
https://doi.org/10.1111/j.1526-4637.2011.01253.x
https://doi.org/10.1111/j.1526-4637.2011.01253.x
Autor:
Dahong Yu, Wenjin Wang, Edward Michna, Arnold J. Weil, Haiying Zhang, Marc Duerden, Amy Manley, Bruce Randazzo, Seth Schulman, Evan Tzanis
Publikováno v:
Pain Medicine. 12:1223-1230
Objective. Methylnaltrexone, a selective peripherally acting mu-opioid receptor antagonist, effectively treats opioid-induced constipation (OIC) in patients with advanced illness and shows efficacy in patients with chronic nonmalignant pain. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c69a8a9761bb00e07838894d8c5a6c
https://doi.org/10.1111/j.1526-4637.2011.01189.x
https://doi.org/10.1111/j.1526-4637.2011.01189.x
Autor:
Arnold J. Weil
Publikováno v:
Therapy. 6:871-881
Low back and neck pain are common clinical complaints that have a substantial social impact and incur considerable direct and indirect costs. Skeletal muscle relaxants (SMRs) are one of a number of therapy options for patients with these conditions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb525f63fd60360f5c16b9553112c8a3
https://doi.org/10.2217/thy.09.62
https://doi.org/10.2217/thy.09.62
Autor:
Arnold J. Weil, Charles A. Altman, David G. Borenstein, Fang Xie, Gary E. Ruoff, Gerard A. Malanga
Publikováno v:
Current Medical Research and Opinion. 25:1179-1196
To evaluate efficacy and tolerability of once-daily cyclobenzaprine extended release (CER) 15- and 30-mg capsules in patients with muscle spasm associated with acute, painful musculoskeletal conditions.Two identically designed, randomized, double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3990c723ea2ea8f2cd09c13543008d
https://doi.org/10.1185/03007990902851753
https://doi.org/10.1185/03007990902851753
Publikováno v:
Current Medical Research and Opinion. 22:1503-1514
To assess the long-term efficacy, tolerability and safety of polymer-coated extended-release morphine sulfate (P-ERMS) (KADIAN) compared with controlled-release oxycodone HCl (CRO) (OxyContin) in treating chronic, nonmalignant, moderate to severe pai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b82423cd4555beb95535f5c76155802
https://doi.org/10.1185/030079906x115603
https://doi.org/10.1185/030079906x115603
Publikováno v:
Current therapeutic research, clinical and experimental. 68(3)
Background:Opioid analgesics may offer benefits over nonopioids in some older patients, especially those with moderate-to-severe pain. Polymer-coated extended-release morphine sulfate (P-ERMS) has been found to be efficacious and well tolerated in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ae5c3a33d3eb774af9a35a4cd9167b
https://pubmed.ncbi.nlm.nih.gov/24683205
https://pubmed.ncbi.nlm.nih.gov/24683205
Publikováno v:
Current medical research and opinion. 22(3)
To demonstrate the efficacy and tolerability of polymer-coated extended-release morphine sulfate (P-ERMS)(KADIAN) for the treatment of chronic, moderate-to-severe, non-malignant pain in a community-based outpatient population not satisfactorily relie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::941e4474748bd8d9467180bd2875f457
https://pubmed.ncbi.nlm.nih.gov/16574037
https://pubmed.ncbi.nlm.nih.gov/16574037